Molecular pathogenesis of subarachnoid haemorrhage
Molecular pathogenesis of subarachnoid haemorrhage
Subarachnoid haemorrhage (SAH) results from leakage of blood into the subarachnoid space and carries high morbidity and mortality. However, there is limited understanding to date, of the risk factors, cellular, intermediate biochemical and genetic traits predisposing to SAH. Nevertheless, in conjunction with improved methods of diagnostic imaging and less invasive approaches to preventing aneurysmal rupture, there may be utility in gaining a better understanding of the pathogenesis and in identifying pre-disease markers. Additionally, it is not impossible that drugs of value (e.g. matrix or endothelial modifiers) could become available. Several different clinical subtypes can be recognised, distinguished by arterial or venous involvement, presence of unruptured arterial aneurysms, and apparently ‘sporadic’ and ‘familial’ occurrences. Epidemiological risk factors include alcohol consumption and smoking: hypertension is a risk factor for rupture. About 10% seem to reflect strong family history and this subset may be particularly illuminating with respect to the molecular pathogenesis. Haemodynamic stress and poor vascular structure may be the main mechanisms of pathogenesis. The epidemiological and statistical evidence for familial megaphenic genes and modifier genes is reviewed. This review focuses on the pathogenesis, as opposed to inflammatory response to SAH. It sets in context the roles of specific genes and their protein products, such as polycystin (PKD1), fibrillin (FBN1), collagen III (COL3A1), elastin (ELN), collagen IV, protease inhibitor or ?1-antitrypsin (PI) and proteases. These considerations illustrate the shortfalls in current knowledge, the needs of future biochemical and cellular research and their potential implications for future prevention of this often fatal condition.
subarachnoid haemorrhage, stroke, collagen, elastin, aneurysm, intracranial aneurysm
1341-1360
Zhang, Baiping
94e2efcc-d26f-41df-9069-9be5db88a5a1
Fugleholm, Kaare
c9404bcf-4b64-403a-aea4-dc33d0259cc5
Day, Lorna B.
e2afd522-a3f5-4b13-9da9-7f6f6306bc82
Ye, Shu
132b6474-1927-4f93-80db-2c620a31c1ab
Weller, Roy O.
4a501831-e38a-4d39-a125-d7141d6c667b
Day, Ian N.M.
b749b30a-1f4c-40eb-af0e-a50427388b39
2003
Zhang, Baiping
94e2efcc-d26f-41df-9069-9be5db88a5a1
Fugleholm, Kaare
c9404bcf-4b64-403a-aea4-dc33d0259cc5
Day, Lorna B.
e2afd522-a3f5-4b13-9da9-7f6f6306bc82
Ye, Shu
132b6474-1927-4f93-80db-2c620a31c1ab
Weller, Roy O.
4a501831-e38a-4d39-a125-d7141d6c667b
Day, Ian N.M.
b749b30a-1f4c-40eb-af0e-a50427388b39
Zhang, Baiping, Fugleholm, Kaare, Day, Lorna B., Ye, Shu, Weller, Roy O. and Day, Ian N.M.
(2003)
Molecular pathogenesis of subarachnoid haemorrhage.
International Journal of Biochemistry & Cell Biology, 35 (9), .
(doi:10.1016/S1357-2725(03)00043-8).
Abstract
Subarachnoid haemorrhage (SAH) results from leakage of blood into the subarachnoid space and carries high morbidity and mortality. However, there is limited understanding to date, of the risk factors, cellular, intermediate biochemical and genetic traits predisposing to SAH. Nevertheless, in conjunction with improved methods of diagnostic imaging and less invasive approaches to preventing aneurysmal rupture, there may be utility in gaining a better understanding of the pathogenesis and in identifying pre-disease markers. Additionally, it is not impossible that drugs of value (e.g. matrix or endothelial modifiers) could become available. Several different clinical subtypes can be recognised, distinguished by arterial or venous involvement, presence of unruptured arterial aneurysms, and apparently ‘sporadic’ and ‘familial’ occurrences. Epidemiological risk factors include alcohol consumption and smoking: hypertension is a risk factor for rupture. About 10% seem to reflect strong family history and this subset may be particularly illuminating with respect to the molecular pathogenesis. Haemodynamic stress and poor vascular structure may be the main mechanisms of pathogenesis. The epidemiological and statistical evidence for familial megaphenic genes and modifier genes is reviewed. This review focuses on the pathogenesis, as opposed to inflammatory response to SAH. It sets in context the roles of specific genes and their protein products, such as polycystin (PKD1), fibrillin (FBN1), collagen III (COL3A1), elastin (ELN), collagen IV, protease inhibitor or ?1-antitrypsin (PI) and proteases. These considerations illustrate the shortfalls in current knowledge, the needs of future biochemical and cellular research and their potential implications for future prevention of this often fatal condition.
This record has no associated files available for download.
More information
Published date: 2003
Keywords:
subarachnoid haemorrhage, stroke, collagen, elastin, aneurysm, intracranial aneurysm
Identifiers
Local EPrints ID: 25056
URI: http://eprints.soton.ac.uk/id/eprint/25056
ISSN: 1357-2725
PURE UUID: ca6a0f2a-5431-40a4-b78a-ce37626676be
Catalogue record
Date deposited: 04 Apr 2006
Last modified: 15 Mar 2024 07:00
Export record
Altmetrics
Contributors
Author:
Baiping Zhang
Author:
Kaare Fugleholm
Author:
Lorna B. Day
Author:
Shu Ye
Author:
Roy O. Weller
Author:
Ian N.M. Day
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics